170108-06-2

Basic information

• Product Name: 2-bromo-4-chloro-3-fluorobenzoic acid
• Synonyms: 2-bromo-4-chloro-3-fluorobenzoic acid
• CAS NO: 170108-06-2
• Molecular Weight: 253.455
• Mol File: 170108-06-2.mol
• Article Data: 11

Chemical Properties

• CAS DataBase Reference: 2-bromo-4-chloro-3-fluorobenzoic acid(CAS DataBase Reference)
• NIST Chemistry Reference: 2-bromo-4-chloro-3-fluorobenzoic acid(170108-06-2)
• EPA Substance Registry System: 2-bromo-4-chloro-3-fluorobenzoic acid(170108-06-2)

Safety Data

• Hazardous Substances Data: 170108-06-2(Hazardous Substances Data)

Upstream product

• 403-17-8 4-chloro-3-fluorobenzoic acid 

Downstream Products

• 1187649-65-5 C₇H₂BrCl₂FO 
• 1352423-57-4 (E)-3-(3-chloro-6-cyano-2-fluorophenyl)acrylic acid 
• 1430115-48-2 (E)-methyl 3-(3-chloro-6-cyano-2-fluorophenyl)acrylate 
• 1430115-47-1 2-bromo-4-chloro-3-fluorobenzonitrile 

Relevant articles and documents

SUBSTITUTED OXOPYRIDINE DERIVATIVES

The invention relates to substituted oxopyridine derivatives and to processes for their preparation, and also to their use for preparing medicaments for the treatment and/or prophylaxis of diseases, in particular vascular disorders, preferably thrombotic

PYRIDINE-1-OXIDE DERIVATIVES AND THEIR USE AS FACTOR XIA INHIBITORS

The present invention provides a compound of Formula (I) and pharmaceutical compositions comprising one or more said compounds, and methods for using said compounds for treating or preventing thromboses, embolisms, hypercoagulability or fibrotic changes. The compounds are selective Factor XIa inhibitors or dual inhibitors of Factor XIa and plasma kallikrein.

FACTOR XIA INHIBITORS

The present invention provides a compound of Formula I(The chemical formula should be inserted here.) and pharmaceutical compositions comprising one or more said compounds, and methods for using said compounds for treating or preventing thromboses, embolisms, hypercoagulability or fibrotic changes. The compounds are selective Factor XIa inhibitors or dual inhibitors of Factor XIa and plasma kallikrein.